8VC Research
Investment Thesis
8VC is a technology and bio-sciences venture capital firm that partners with elite founders to build transformational technologies creating long-term economic and societal value. Founded in 1999 (rebranded as 8VC in 2013), the firm was inspired by the story of the "Traitorous Eight" who left Shockley Semiconductor to found Fairchild Semiconductor, founding Silicon Valley itself. This heritage shapes 8VC's philosophy of positive-sum thinking, embracing contrarianism, and empowering individuals to do their best work.
Core Philosophy and Values
8VC's investment approach is built on several foundational principles:
Take it Personally: The firm's work is their art, with deep personal commitment to portfolio company success.
Stewardship: Partners act as fiduciaries and stewards to limited partners and to principles, the firm, and the innovation ecosystem.
Positive Sum: The belief that success in all forms gives rise to more success. The firm focuses on doing its part rather than getting its share.
Principled Contrarianism: Being different gets attention; being different and right can change the world.
Patriotism: The firm believes in the American experiment and its ideals, with a commitment to defending people and institutions.
Smart Enterprise Thesis
8VC's foundational thesis, written in 2013, posited that the "smart enterprise wave will disrupt nearly every major sector of the global economy." The Smart Enterprise concept centers on:
- Leveraging the power of data integration
- Enabling human experts to solve non-linear problems
- Building platforms and harnessing network effects to take on entire problem spaces
This overarching thesis manifests across five primary industry verticals: Logistics, Life Sciences, Healthcare, IT Infrastructure, and Government & Defense.
Investment Strategy by Sector
Logistics: 8VC invests in platforms that help logistics companies become modern data enterprises. Key applications include streamlining resources, fleet operations, and finance; leveraging telematics for better performance; and building next-generation transportation forms. Portfolio companies include Flexport, Deliverr, and Terminal Logistics.
Life Sciences: The firm combines specialized fields such as cell therapy, synthetic biology, biomanufacturing, microfluidics, and genomics-IT with approaches like CRISPR and AI to unlock exponential breakthroughs for patients. This vertical is experiencing particular growth, evidenced by recent investments and partnerships around rare disease medicine.
Healthcare: 8VC recognizes that US healthcare is at an inflection point with unprecedented demand for better quality and accessibility. The firm backs tech-enabled care models, robust and scalable IT systems, and solutions for underserved populations. Portfolio companies include Hopscotch, Candid Health, and Digital Diagnostics.
IT Infrastructure: As enterprises transition to cloud-native environments, 8VC invests in next-generation companies rewriting rules for data infrastructure and application software. These horizontal platforms are optimized for power and precision at unprecedented scale. Portfolio companies include Twingate, Lightbeam AI, and SeeMetrics.
Government & Defense: Inspired partly by the firm's experience building Palantir, 8VC backs GovTech companies helping public servants harness data integration and modern architecture to make government more transparent, efficient, and responsive. Portfolio companies include Anduril, Epirus, and Esper.
Fund History and AUM
8VC has successfully raised six flagship funds:
- Fund I-IV: Established track record and industry reputation
- Fund V (2023): Crossed $6 billion in committed capital
- Fund VI (2025): $998 million in new capital (March 2025 close)
Total Assets Under Management: Approximately $7 billion (combining Fund V's $6B+ with Fund VI's $998M)
Investment Activity and Pace
8VC has made 743 investments across its portfolio companies and maintains an active deployment schedule. Recent investments include partnerships in life sciences, healthcare, and logistics sectors. Strategic partnerships with major institutions have been announced, including an Apollo partnership in November 2025 for industrial innovation.
The firm has 20+ open positions, indicating active hiring and deployment.
Stage Focus and Check Size
Investment Stages: Pre-seed, Seed, Series A, and selective Series B follow-on investments
Check Size: $500K - $50M range
- Early stage (Pre-seed/Seed): $500K - $5M
- Series A: $5M - $20M+
- Follow-on reserves: Significant capacity for existing portfolio companies
Team and Leadership
Investment Team includes over 25 professionals across investment, portfolio support, operations, and finance/legal/IR functions.
Key advisors and board members represent exceptional depth across sectors:
- Scott Cook (Founder, Intuit; Early Board Member, eBay)
- Stephen Harper (22nd Prime Minister of Canada)
- Jerry Yang (Founder, Yahoo!)
- Ashton Kutcher (Founder, Sound Ventures)
- Arie Belldegrun, MD (Founder, Kite Pharma and multiple biotech companies)
- Various C-suite executives from Walmart, UPS, Schneider, Amazon, Cleveland Clinic, and others
Geographic Focus
Primary: Austin, Texas (headquarters)
Secondary: San Francisco Bay Area, with presence across US markets
Selective: Global investments where founder quality and opportunity align
Notable Portfolio Companies
Recent notable investments include:
- Bedrock Robotics (Advanced manufacturing)
- Ramp (Expense management)
- Casetext (AI-powered legal platform)
- Saronic (Autonomous surface vessels)
- Hopscotch (Healthcare platform)
- Vercel (Frontend deployment)
- Anduril (Defense technology)
- Epirus (Counter-drone systems)
- YugaByte (Database infrastructure)
- Resilience (Pharmaceutical manufacturing)
- Orca Bio (Cell therapy)
- Guardant Health (Cancer diagnostics)
- City Block (Healthcare for underserved communities)
- Flexport (Digital freight forwarding)
- Project44 (Supply chain visibility)
- Commure (Healthcare data platform)
- Addepar (Wealth management software)
Build Program
8VC operates a unique Build program where the firm co-founds companies rather than simply investing in external founders. Since 2016, the Build program has founded 21 companies, addressing market gaps and creating investment opportunities where compelling companies didn't yet exist.
Fellowship Programs
8VC offers multiple fellowship programs to attract exceptional technologists:
- 8VC Fellowship: For rising technologists wanting to contribute to ambitious portfolio companies
- Engineering Fellowship: Technical specialty track
- Bio-IT Fellowship: For specialists in biology and computational biology
Decision Process and Timeline
Decision Structure: Partnership-based with collaborative decision making among general partners
Timeline: Estimated 2-4 weeks for seed stage decisions, with acceleration for strong founder fits
Recent Activity (Last 12 Months)
As of early 2026, 8VC remains actively deploying:
- Announced Terra Industries partnership (January 2026) - Africa's first modern defense prime
- Published research on rare disease medicine opportunity (January 2026)
- Announced partnership with Bobyard on manufacturing innovation (December 2025)
- Apollo partnership announcement (November 2025) for industrial innovation
- Fund VI closing (March 2025) with $998M in new capital
The firm is hiring across all functions and actively seeking investment opportunities, particularly in life sciences, healthcare, logistics, IT infrastructure, and government/defense sectors.
Summary
8VC is a large, actively deploying multi-stage venture capital firm with exceptional depth of expertise and network across five primary sectors. The firm combines deep sector knowledge, operational support, access to world-class advisors, and a unique Build program that creates investment opportunities. With approximately $7 billion in AUM and a 25+ year history (rebranded in 2013), 8VC targets founders with ambitious visions solving fundamental problems across enterprise, industrial, and national capability domains.